PDK1 and clear cell renal carcinoma: Previous research has indicated that FTO promotes PDK1 expression by preventing the YTHDF2‐induced degradation of PDK1 mRNA via an m6A‐dependent mechanism, thereby facilitating the proliferation and migration of clear cell renal cell carcinoma.63